We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEB
801
DELISTED
CEB Inc.
CEB
| $204K | ﹤0.01% |
+2,743
| New | +$206K |
|
|
SWFT
802
DELISTED
Swift Transportation Company
SWFT
| $204K | ﹤0.01% |
8,234
-133,166
| -94% | -$3.08M |
|
803
Avery Dennison
AVY
$13B
| $203K | ﹤0.01% |
4,000
-37,276
| -90% | -$1.86M |
|
804
Camden Property Trust
CPT
$11B
| $203K | ﹤0.01% |
+3,011
| New | +$192K |
|
805
Keurig Dr Pepper
KDP
$42.3B
| $203K | ﹤0.01% |
3,726
-2,523
| -40% | -$127K |
|
806
MGE Energy Inc
MGEE
$3B
| $203K | ﹤0.01% |
+5,161
| New | +$197K |
|
|
GMCR
807
DELISTED
KEURIG GREEN MTN INC
GMCR
| $203K | ﹤0.01% |
1,917
-101,742
| -98% | -$10.1M |
|
|
HRG
808
DELISTED
HRG Group, Inc.
HRG
| $203K | ﹤0.01% |
16,566
+5,351
| +48% | +$63K |
|
809
Xerox
XRX
$387M
| $198K | ﹤0.01% |
6,636
+796
| +14% | +$23.3K |
|
|
BEL
810
DELISTED
Belmond Ltd.
BEL
| $192K | ﹤0.01% |
+13,285
| New | +$195K |
|
|
VNET
811
VNET Group
VNET
$2.04B
| $187K | ﹤0.01% |
6,498
-181,648
| -97% | -$4.53M |
|
|
IPG
812
DELISTED
Interpublic Group of Companies
IPG
| $185K | ﹤0.01% |
+10,736
| New | +$184K |
|
813
SITE Centers
SITC
$225M
| $170K | ﹤0.01% |
+7,974
| New | +$164K |
|
814
Avis
CAR
$4.86B
| $161K | ﹤0.01% |
+3,298
| New | +$142K |
|
815
Ford
F
$58.5B
| $161K | ﹤0.01% |
10,260
-76,270
| -88% | -$1.18M |
|
816
LXP Industrial Trust
LXP
$3.57B
| $159K | ﹤0.01% |
2,899
-631
| -18% | -$34.2K |
|
|
FTR
817
DELISTED
Frontier Communications Corp.
FTR
| $154K | ﹤0.01% |
1,799
+399
| +29% | +$29.2K |
|
|
PLCM
818
DELISTED
POLYCOM INC
PLCM
| $151K | ﹤0.01% |
10,961
-3,405
| -24% | -$42.7K |
|
|
ANR
819
DELISTED
Alpha Natural Resources Inc
ANR
| $150K | ﹤0.01% |
35,183
-24,417
| -41% | -$131K |
|
|
CAA
820
DELISTED
CalAtlantic Group, Inc.
CAA
| $147K | ﹤0.01% |
+3,530
| New | +$153K |
|
|
CY
821
DELISTED
Cypress Semiconductor
CY
| $146K | ﹤0.01% |
+14,187
| New | +$144K |
|
|
PMCS
822
DELISTED
P M C SIERRA INC
PMCS
| $138K | ﹤0.01% |
+18,112
| New | +$127K |
|
823
MGIC Investment
MTG
$6.16B
| $135K | ﹤0.01% |
+15,819
| New | +$138K |
|
|
JNS
824
DELISTED
Janus Capital Group Inc
JNS
| $135K | ﹤0.01% |
+12,359
| New | +$140K |
|
|
CYS
825
DELISTED
CYS Investments Inc.
CYS
| $116K | ﹤0.01% |
+13,931
| New | +$115K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.